Search results
IBD Stock Of The Day Eli Lilly Surges After Weight-Loss Drug Obliterates Sales Views
Investor's Business Daily· 4 days agoThis pushed Lilly to raise its sales outlook for the year by $2 billion, despite short revenue from...
Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised
Zacks· 5 days agoEli Lilly (LLY) beats first-quarter estimates for earnings but misses the same for sales. It raises...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Crushes Quarterly Sales Forecasts?
Investor's Business Daily· 4 days agoIn the first quarter, sales of both rocketed higher, but only Zepbound sales topped expectations....
Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast
Benzinga via Yahoo Finance· 4 days agoThe volume increase was primarily driven by growth from Mounjaro, Zepbound, Verzenio, and Jardiance,...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 1 day agoStrong demand for Mounjaro, Zepbound, Verzenio and Jardiance pulled the top line in the quarter....
Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb
BioPharma Dive via Yahoo Finance· 4 days agoLilly noted that its so-called “incretin medicines” — a group that also includes its earlier...
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoEli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript April 30, 2024 Eli Lilly and...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 4 days agoEli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly ...
Decoding Eli Lilly and Co (LLY): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 days agoHowever, this was partially offset by decreased sales of Trulicity. The company's net income and...
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Associated Press via Yahoo Finance· 4 days agoRapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro,...